Volume 141, Issue 2, Pages 442-450 (February 2012) Risk Factors and Outcome of Pulmonary Complications After Autologous Hematopoietic Stem Cell Transplant Bekele Afessa, MD, FCCP, Raolat M. Abdulai, MD, Walter K. Kremers, PhD, William J. Hogan, MB, Mark R. Litzow, MD, Steve G. Peters, MD, FCCP CHEST Volume 141, Issue 2, Pages 442-450 (February 2012) DOI: 10.1378/chest.10-2889 Copyright © 2012 The American College of Chest Physicians Terms and Conditions
Figure 1 Diagnostic approach of the HSCT recipient with pulmonary symptoms and/or signs. HRCT = high-resolution CT; PFT = pulmonary function test; TBB = transbronchial lung biopsy; VATS = video-assisted thoracoscopic surgery. CHEST 2012 141, 442-450DOI: (10.1378/chest.10-2889) Copyright © 2012 The American College of Chest Physicians Terms and Conditions
Figure 2 Cumulative incidence of bacterial, fungal, and viral pulmonary complications. CHEST 2012 141, 442-450DOI: (10.1378/chest.10-2889) Copyright © 2012 The American College of Chest Physicians Terms and Conditions
Figure 3 Cumulative incidence of selected noninfectious complications. APE = acute pulmonary edema; DAH = diffuse alveolar hemorrhage; IPS = idiopathic pneumonia syndrome; PERDS = peri-engraftment respiratory distress syndrome. CHEST 2012 141, 442-450DOI: (10.1378/chest.10-2889) Copyright © 2012 The American College of Chest Physicians Terms and Conditions
Figure 4 Patient survival following hematopoietic stem cell transplant. PC = pulmonary complication. CHEST 2012 141, 442-450DOI: (10.1378/chest.10-2889) Copyright © 2012 The American College of Chest Physicians Terms and Conditions